Can the law play a role in overcoming hesitancy about the COVID-19 vaccine? Sarah Moore, partner at Hausfeld, explores the possibilities for NLJ this week
Ironically, the swiftness with which the vaccine has passed its regulatory checks may have increased the misgivings of some of those reluctant.
Moore looks at regulators’ responses, the impact of politicians suggesting Brexit speeding up approval, suggestions for a no-fault compensation scheme to be established and the Vaccine Damage Payments Act 1979.
RELATED ARTICLES
